Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome
Pediatric Neurology , 08/10/09
Degrauw RS et al.– For children and adolescents with Tourette syndrome treated >1 yr with neuroleptic agents, findings show that weight gain is not excessive for all cases.
Methods- Study of effects of neuroleptic agents on body mass index for age and sex (body mass index Z scores) in matched cohort of 16 neuroleptic-treated and 29 nonneuroleptic-treated children and adolescents with Tourette syndrome
- Assessment of growth parameters in 45 children, age 5-15 yrs, treated for 3-yr average (range, 1-6) with low doses of pimozide or risperidone
- Regression analysis for effects of neuroleptic treatment, age, duration, and treatment X duration interactions on changes in Z score
- Repeat measures analysis of variance for time course of changes
- Mean first-yr weight gain differed significantly (13.5 kg neuroleptic vs 3.2 kg nonneuroleptic)
- Long-term Z score changes did not differ significantly
- Repeated measures analysis of Z scores differed significantly by treatment, related to first-year changes only
Related Articles
Streptococcal infection, Tourette syndrome, and OCD. Is there a connection
Neurology, 10/05/09
Relevance Score: 69%
Cannabinoids for Tourette's Syndrome
Cochrane Reviews, 10/22/09
Relevance Score: 67%
Association of Intronic Variants of the BTBD9 Gene With Tourette Syndrome
Archives of Neurology, 10/15/09
Relevance Score: 67%
Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case–control study
Vascular Medicine, 10/13/09
Relevance Score: 67%
The association of metabolic syndrome with triple-negative breast cancer
Breast Cancer Research and Treatment, 10/28/09
Relevance Score: 66%
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of Fibrinogen with Parkinson Disease in Elderly Japanese-American Men: A Prospective Study
Neuroepidemiology , 11/27/09
Stimulation-Induced Dyskinesia in the Early Stage after Subthalamic Deep Brain Stimulation
Stereotactic and Functional Neurosurgery , 11/25/09
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines
Acta Neurologica Scandinavica, 11/27/09
Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia
Journal of Pharmacology and Experimental Therapeutics, 11/25/09
Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial
Acta Neurologica Scandinavica, 11/25/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines
Acta Neurologica Scandinavica, 11/27/09
Propylene Glycol Accumulation in Critically Ill Patients Receiving Continuous Intravenous Lorazepam Infusions
Annals of Pharmacotherapy, 11/25/09
Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial
Acta Neurologica Scandinavica, 11/25/09
Article Search
Sponsor


See Latest Articles


